[go: up one dir, main page]

UY26835A1 - Agente para inhibir la adhesión de la flora patogénica de la piel - Google Patents

Agente para inhibir la adhesión de la flora patogénica de la piel

Info

Publication number
UY26835A1
UY26835A1 UY26835A UY26835A UY26835A1 UY 26835 A1 UY26835 A1 UY 26835A1 UY 26835 A UY26835 A UY 26835A UY 26835 A UY26835 A UY 26835A UY 26835 A1 UY26835 A1 UY 26835A1
Authority
UY
Uruguay
Prior art keywords
patogenic
flora
inhibit
adhesion
skin
Prior art date
Application number
UY26835A
Other languages
English (en)
Inventor
Jean Richard Nesser
Isabelle Auzanneau
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169257&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY26835(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of UY26835A1 publication Critical patent/UY26835A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/986—Milk; Derivatives thereof, e.g. butter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe el uso de un derivado de caseína para la preparación de una composición para uso cosmético, farmacéutico o veterinario, propuesta para ser administrada a humanos o a animales para el propósito de prevenir o tratar trastornos inducidos por los agentes patógenos del sistema cutáneo.
UY26835A 2000-07-14 2001-07-12 Agente para inhibir la adhesión de la flora patogénica de la piel UY26835A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00115274 2000-07-14

Publications (1)

Publication Number Publication Date
UY26835A1 true UY26835A1 (es) 2002-01-31

Family

ID=8169257

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26835A UY26835A1 (es) 2000-07-14 2001-07-12 Agente para inhibir la adhesión de la flora patogénica de la piel

Country Status (14)

Country Link
US (1) US20030161850A1 (es)
EP (1) EP1303295B1 (es)
JP (1) JP2004503597A (es)
AR (1) AR029829A1 (es)
AT (1) ATE339217T1 (es)
AU (1) AU2001287560A1 (es)
CA (1) CA2415918C (es)
DE (1) DE60123067T2 (es)
DK (1) DK1303295T3 (es)
ES (1) ES2272535T3 (es)
PE (1) PE20020147A1 (es)
PT (1) PT1303295E (es)
UY (1) UY26835A1 (es)
WO (1) WO2002005839A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0321996D0 (en) * 2003-09-19 2003-10-22 Novartis Nutrition Ag Organic compounds
US7332179B2 (en) 2003-12-12 2008-02-19 Kimberly-Clark Worldwide, Inc. Tissue products comprising a cleansing composition
US7642395B2 (en) 2004-12-28 2010-01-05 Kimberly-Clark Worldwide, Inc. Composition and wipe for reducing viscosity of viscoelastic bodily fluids
CA2699170A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
WO2011132191A1 (en) 2010-04-21 2011-10-27 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7786M (es) * 1968-10-07 1970-03-23
FR8087M (es) * 1968-10-08 1970-07-20
US3764670A (en) * 1970-10-28 1973-10-09 Ministry Of Agriculture Polypeptidic anti-biotic substances derived from casein
DE3049038A1 (de) * 1980-12-24 1982-07-15 Marie 8000 München Hauck Mittel zur bekaempfung von hautkrankheiten
US4525351A (en) * 1983-01-11 1985-06-25 Chr. Hansen's Laboratory, Inc. Liquid adherent disinfectant compositions for topical application and method of preparation
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
CH671879A5 (es) * 1987-02-26 1989-10-13 Nestle Sa
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
US5681586A (en) * 1989-03-23 1997-10-28 Gordon; Arthur L. Enzyme-modified soy and soy/casein combination healing compositions
US5166132A (en) * 1989-03-23 1992-11-24 Gordon Arthur L Healing composition employing an enzyme-modified casein
JP2673320B2 (ja) * 1990-01-25 1997-11-05 雪印乳業株式会社 う蝕原菌付着阻止剤
FR2657525B1 (fr) * 1990-01-26 1994-07-29 Dubois Jacques Produits dermo-cosmetiques nouveaux pour le nettoyage et le soin de la peau et/ou des cheveux.
EP0760673A1 (en) * 1994-05-26 1997-03-12 Abbott Laboratories INHIBITION OF ATTACHMENT OF $i(H. INFLUENZAE) TO HUMAN CELLS
WO1998046240A1 (en) * 1997-04-15 1998-10-22 Advanced Viral Research Corp. Topical treatment of skin diseases and eye afflictions

Also Published As

Publication number Publication date
EP1303295A1 (en) 2003-04-23
JP2004503597A (ja) 2004-02-05
DK1303295T3 (da) 2007-01-02
US20030161850A1 (en) 2003-08-28
EP1303295B1 (en) 2006-09-13
PE20020147A1 (es) 2002-02-26
DE60123067D1 (de) 2006-10-26
AR029829A1 (es) 2003-07-16
CA2415918A1 (en) 2002-01-24
ATE339217T1 (de) 2006-10-15
DE60123067T2 (de) 2007-04-12
ES2272535T3 (es) 2007-05-01
WO2002005839A1 (en) 2002-01-24
PT1303295E (pt) 2007-01-31
CA2415918C (en) 2010-06-01
AU2001287560A1 (en) 2002-01-30

Similar Documents

Publication Publication Date Title
DK1294383T3 (da) Orale sammensætninger omfattende antimikrobielle midler til at forhindre systemiske sygdomme
AR030068A1 (es) Composiciones farmaceuticas para el tratamiento de condiciones dolorosas, inflamatorias y ulcerosas de superficies epiteliales humedas como por ejemplo mucositis, estomatitis y sindrome de behcet
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
HN2000000115A (es) Formulacion de sal comun y moxifloxacina
AR032556A1 (es) Medicamento de accion inmediata para el tratamiento de la disfuncion sexual
MX9604208A (es) Gel para el tratamiento de enfermedades de la piely para la desinfeccion de la piel.
HN1999000124A (es) Derivados de pirazol substituido.
PA8452001A1 (es) Derivados de macrolidos c-4" sustituidos
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
ES2077530B1 (es) Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
AR073606A1 (es) Metodo de uso de una cepa de bacillus subtilis para mejorar la salud de animales
BR0011116A (pt) Usos de uma nsaid que libera no como um sal farmaceuticamente aceitável ou um enanciÈmero do mesmo, e de uma nsaid que libera no e de um inibidor de bomba de próton suscetìvel a ácido ou um sal do mesmo ou um enanciÈmero ou de um sal do enanciÈmero, método para o tratamento de uma infecção bacteriana, e, formulação farmacêutica adequada para uso no tratamento de infecções bacterianas
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
AR098251A2 (es) Uso de aivlosin o de una sal de adición ácida del mismo farmacológicamente aceptada para la preparación de un medicamento de uso veterinario, un alimento para aves de corral o cerdos, una composición recubierta estable para ser agregada a dicho alimento y un medicamento de uso veterinario
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
BRPI0406858A (pt) Liberação controlada de agentes altamente solúveis
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
BR0010983A (pt) Preparações para a aplicação de agentes antiinflamatórios
UY26835A1 (es) Agente para inhibir la adhesión de la flora patogénica de la piel
ES2177671T3 (es) Benzamida enterocinetica.
SV2003000928A (es) Conjugados de pregabalina-lactosa ref. pca513-01
BR0116653A (pt) Medicamento contendo uma poliamina como substância ativa
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140523